Clinical Evidence of Muscle Loss Recent research has underscored the risks inherent in unsupervised GLP-1 use
In less common cases, more serious risks such as pancreatitis, gallbladder-related issues, or kidney complications may occur, particularly in individuals with underlying medical conditions
If you have ulcerative colitis and are considering GLP-1 therapy, integrating genetic predisposition data with your baseline disease markers and provider expertise can help ensure safer, more personalized treatment planning
[8] Wu Y, Lin L, Wang X, et al
Each plan is designed to address hormonal imbalances, metabolic resistance, and the unique biological factors that often go overlooked in traditional weight loss models and stand in the way of results
Studies have found that Epitalon restored melatonin formation in the pineal body of older monkeys, increased superoxide dismutase (SOD) activity, and reduced the amount of LPO products, diene conjugates, and ROS [23, 33, 34]